James Investment Research, Inc.
Source: SEC Form 13F · as of Mar 2026James Investment Research, Inc. holds 26 biotech & pharma companies tracked by BioSniper, totaling $53.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
26
Total value held
$53.2M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 10,858 | $10.0M |
| JNJJOHNSON & JOHNSON | 34,583 | $8.5M |
| ABBVAbbVie Inc. | 34,553 | $7.5M |
| ABTABBOTT LABORATORIES | 52,861 | $5.4M |
| AZNASTRAZENECA PLC | 24,071 | $4.7M |
| MCKMcKesson Corporation | 3,785 | $3.3M |
| UTHRUNITED THERAPEUTICS Corp | 3,253 | $1.9M |
| INVAInnoviva, Inc. | 77,227 | $1.8M |
| HALOHALOZYME THERAPEUTICS, INC. | 26,327 | $1.7M |
| AMGNAMGEN INC | 4,204 | $1.5M |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | 21,004 | $1.1M |
| CPRXCATALYST PHARMACEUTICALS, INC. | 33,685 | $834K |
| ELVElevance Health Inc. | 2,752 | $806K |
| CORTCORCEPT THERAPEUTICS INC | 17,122 | $690K |
| EBSEmergent BioSolutions Inc. | 61,963 | $514K |
| ALKSAlkermes plc. | 10,285 | $364K |
| ANIPANI PHARMACEUTICALS INC | 4,650 | $358K |
| PAHCPHIBRO ANIMAL HEALTH CORP | 6,260 | $346K |
| KNSAKiniksa Pharmaceuticals International, plc | 7,027 | $338K |
| SIGASIGA TECHNOLOGIES INC | 53,546 | $286K |
| ZYMEZymeworks Inc. | 10,925 | $274K |
| TBPHTheravance Biopharma, Inc. | 14,833 | $241K |
| COLLCOLLEGIUM PHARMACEUTICAL, INC | 7,110 | $235K |
| PFEPFIZER INC | 7,631 | $214K |
| ZTSZoetis Inc. | 1,727 | $204K |
| IRDOpus Genetics, Inc. | 16,364 | $74K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.